In Vitro Antibacterial Activity of Photoactivated Flavonoid Glycosides Against Acinetobacter Baumannii

Overview

Journal AMB Express

Date 2024 Nov 4

PMID 39495421

Authors

Maryam Pourhajibagher

Zahra Javanmard

Abbas Bahador

Affiliations

Soon will be listed here.

Abstract

Acinetobacter baumannii's extensive antibiotic resistance makes its infections difficult to treat, so effective strategies to fight this bacterium are urgently needed. This study aims to evaluate the effectiveness of antimicrobial photodynamic therapy (aPDT) mediated by Rutin-Gal(III) complex and Quercetin against A. baumannii. Absorbance spectra, fluorescence spectra, and minimum inhibitory concentration (MIC) of Rutin-Gal(III) complex and Quercetin were determined. The intracellular reactive oxygen species (ROS), extracellular polymeric substances (EPS), cell membrane permeability, expression of ompA and bla, anti-biofilm activity, and anti-metabolic activity of Rutin-Gal(III) complex- and Quercetin-mediated aPDT were measured. Rutin-Gal(III) complex and Quercetin revealed absorption peaks in the visible spectra. Quercetin and Rutin-Gal(III) complex displayed fluorescence peaks at 524 nm and 540 nm, respectively. MIC values for the Rutin-Gal(III) complex and Quercetin were 64 µg/mL and 256 µg/mL, respectively. Quercetin- and Rutin-Gal(III) complex-mediated aPDT significantly reduced the colony forming units/mL (58.4% and 67.5%), EPS synthesis (47.4% and 56.5%), metabolic activity (30.5% and 36.3%), ompA (5.5- and 10.5-fold), and bla (4.1-fold and 7.8-fold) genes expression (respectively; all P < 0.05). Quercetin- and Rutin-Gal(III) complex-mediated aPDT enhanced notable biofilm degradation (36.2% and 40.6%), ROS production (2.55- and 2.90-folds), and membrane permeability (10.8- and 9.6-folds) (respectively; all P < 0.05). The findings indicate that Rutin-Gal(III) complex- and Quercetin-mediated aPDT exhibits antibacterial properties and could serve as a valuable adjunctive strategy to conventional antibiotic treatments for A. baumannii infections. One limitation of this study is that it was conducted solely on the standard strain; testing on clinical isolates would allow for more reliable interpretation of the results.

References

Li Y, Sun G, Xie J, Xiao S, Lin C . Antimicrobial photodynamic therapy against oral biofilm: influencing factors, mechanisms, and combined actions with other strategies. Front Microbiol. 2023; 14:1192955. PMC: 10288113. DOI: 10.3389/fmicb.2023.1192955. View

Jiang J, Lv X, Cheng H, Yang D, Xu W, Hu Y . Type I photodynamic antimicrobial therapy: Principles, progress, and future perspectives. Acta Biomater. 2024; 177:1-19. DOI: 10.1016/j.actbio.2024.02.005. View

Neves F, Clemente W, Lincopan N, Paiao I, Neves P, Romanelli R . Clinical and microbiological characteristics of OXA-23- and OXA-143-producing Acinetobacter baumannii in ICU patients at a teaching hospital, Brazil. Braz J Infect Dis. 2016; 20(6):556-563. PMC: 9427641. DOI: 10.1016/j.bjid.2016.08.004. View

Martins Antunes de Melo W, Celiesiute-Germaniene R, Simonis P, Stirke A . Antimicrobial photodynamic therapy (aPDT) for biofilm treatments. Possible synergy between aPDT and pulsed electric fields. Virulence. 2021; 12(1):2247-2272. PMC: 8437467. DOI: 10.1080/21505594.2021.1960105. View

Yang C, Su P, Moi S, Chuang L . Biofilm Formation in : Genotype-Phenotype Correlation. Molecules. 2019; 24(10). PMC: 6572253. DOI: 10.3390/molecules24101849. View

Polat E, Kang K . Natural Photosensitizers in Antimicrobial Photodynamic Therapy. Biomedicines. 2021; 9(6). PMC: 8224061. DOI: 10.3390/biomedicines9060584. View

Davenport E, Call D, Beyenal H . Differential protection from tobramycin by extracellular polymeric substances from Acinetobacter baumannii and Staphylococcus aureus biofilms. Antimicrob Agents Chemother. 2014; 58(8):4755-61. PMC: 4136036. DOI: 10.1128/AAC.03071-14. View

Songca S, Adjei Y . Applications of Antimicrobial Photodynamic Therapy against Bacterial Biofilms. Int J Mol Sci. 2022; 23(6). PMC: 8953781. DOI: 10.3390/ijms23063209. View

Chen S, Wang X, Cheng Y, Gao H, Chen X . A Review of Classification, Biosynthesis, Biological Activities and Potential Applications of Flavonoids. Molecules. 2023; 28(13). PMC: 10343696. DOI: 10.3390/molecules28134982. View

10.

Algorri J, Lopez-Higuera J, Rodriguez-Cobo L, Cobo A . Advanced Light Source Technologies for Photodynamic Therapy of Skin Cancer Lesions. Pharmaceutics. 2023; 15(8). PMC: 10458875. DOI: 10.3390/pharmaceutics15082075. View

11.

Cavallo I, Oliva A, Pages R, Sivori F, Truglio M, Fabrizio G . in the critically ill: complex infections get complicated. Front Microbiol. 2023; 14:1196774. PMC: 10325864. DOI: 10.3389/fmicb.2023.1196774. View

12.

Marion C, Lee J, Sharma L, Park K, Lee C, Liu W . Toll-Like Receptors 2 and 4 Modulate Pulmonary Inflammation and Host Factors Mediated by Outer Membrane Vesicles Derived from Acinetobacter baumannii. Infect Immun. 2019; 87(9). PMC: 6704609. DOI: 10.1128/IAI.00243-19. View

13.

Li H, Zhou X, Huang Y, Liao B, Cheng L, Ren B . Reactive Oxygen Species in Pathogen Clearance: The Killing Mechanisms, the Adaption Response, and the Side Effects. Front Microbiol. 2021; 11:622534. PMC: 7889972. DOI: 10.3389/fmicb.2020.622534. View

14.

Yaikhan T, Chukamnerd A, Singkhamanan K, Nokchan N, Chintakovid N, Chusri S . Genomic Characterization of Mobile Genetic Elements Associated with Multidrug-Resistant Non- Species from Southern Thailand. Antibiotics (Basel). 2024; 13(2). PMC: 10886146. DOI: 10.3390/antibiotics13020149. View

15.

Pourhajibagher M, Boluki E, Chiniforush N, Pourakbari B, Farshadzadeh Z, Ghorbanzadeh R . Modulation of virulence in Acinetobacter baumannii cells surviving photodynamic treatment with toluidine blue. Photodiagnosis Photodyn Ther. 2016; 15:202-12. DOI: 10.1016/j.pdpdt.2016.07.007. View

16.

Pourhajibagher M, Alaeddini M, Etemad-Moghadam S, Esboei B, Bahrami R, Miri Mousavi R . Quorum quenching of Streptococcus mutans via the nano-quercetin-based antimicrobial photodynamic therapy as a potential target for cariogenic biofilm. BMC Microbiol. 2022; 22(1):125. PMC: 9088123. DOI: 10.1186/s12866-022-02544-8. View

17.

de Melo W, Avci P, de Oliveira M, Gupta A, Vecchio D, Sadasivam M . Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection. Expert Rev Anti Infect Ther. 2013; 11(7):669-93. PMC: 4336791. DOI: 10.1586/14787210.2013.811861. View

18.

Deliorman M, Gordesli Duatepe F, Davenport E, Fransson B, Call D, Beyenal H . Responses of Acinetobacter baumannii Bound and Loose Extracellular Polymeric Substances to Hyperosmotic Agents Combined with or without Tobramycin: An Atomic Force Microscopy Study. Langmuir. 2019; 35(27):9071-9083. PMC: 7607972. DOI: 10.1021/acs.langmuir.9b01227. View

19.

Feng Y, Coradi Tonon C, Ashraf S, Hasan T . Photodynamic and antibiotic therapy in combination against bacterial infections: efficacy, determinants, mechanisms, and future perspectives. Adv Drug Deliv Rev. 2021; 177:113941. DOI: 10.1016/j.addr.2021.113941. View

20.

Abdelkarim-Elafifi H, Parada-Avendano I, Arnabat-Dominguez J . Photodynamic Therapy in Endodontics: A Helpful Tool to Combat Antibiotic Resistance? A Literature Review. Antibiotics (Basel). 2021; 10(9). PMC: 8468135. DOI: 10.3390/antibiotics10091106. View